GENOVA, Inc.
Stock Price Chart
2026/07/15 UpdatedPrice Trend
2026/07/15 UpdatedPrice & Trading Details
2026/07/15 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/07/01Dividend History
Updated 2026/07/12| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥30 | 0.0% |
| 2025 | ¥30 | - |
Financial Performance
2026/07/12 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥6,513M | ¥8,683M | ¥10,006M | ¥11,566M |
| Gross Profit | ¥4,790M | ¥6,553M | ¥7,378M | ¥6,470M |
| Operating Income | ¥1,734M | ¥2,301M | ¥2,026M | ¥400M |
| Pretax Income | ¥1,719M | ¥2,342M | ¥2,019M | ¥513M |
| Net Income | ¥1,260M | ¥1,727M | ¥1,413M | ¥275M |
| EPS | ¥73.07 | ¥96.50 | ¥79.78 | - |
| Operating Margin | 26.62% | 26.50% | 20.25% | 3.46% |
| Balance Sheet | ||||
| Total Assets | ¥5,415M | ¥8,199M | ¥8,526M | ¥10,256M |
| Total Equity | ¥4,038M | ¥6,037M | ¥6,999M | ¥6,899M |
| Total Liabilities | ¥1,377M | ¥2,162M | ¥1,528M | ¥3,357M |
| Cash | ¥3,861M | ¥5,966M | ¥5,872M | ¥5,317M |
| Interest-bearing Debt | ¥28M | ¥378M | ¥21M | ¥736M |
| Equity Ratio | 74.58% | 73.63% | 82.08% | 67.26% |
| D/E Ratio | 0.01 | 0.06 | 0.00 | 0.11 |
| Cash Flow | ||||
| Operating CF | ¥1,203M | ¥1,822M | ¥1,195M | ¥54M |
| Investing CF | -¥113M | -¥94M | -¥276M | -¥810M |
| Financing CF | ¥1,131M | ¥377M | -¥1,015M | ¥200M |
| Free CF | ¥1,110M | ¥1,765M | ¥1,059M | -¥47M |
| Efficiency | ||||
| ROE | 31.20% | 28.60% | 20.20% | 3.99% |
| ROA | 23.27% | 21.06% | 16.58% | 2.69% |
Latest IR Information
-
Notice Regarding Executive Officer Personnel Changes
Read more -
Notice of Correction to部分 Amendments to the Consolidated Financial Results for the Fiscal Year Ending March 2026 [Japanese GAAP]
Read more -
Notice of Partial Correction to the Consolidated Financial Results Briefing for the Fiscal Year Ending March 2026 [Japanese Standards] (Revised)
Read more -
Notice Regarding Changes (Scheduled) in Major Shareholders and Principal Shareholders, and Regarding Purchase Acts Prescribed by Ordinance Similar to Tender Offers
It is expected that Heise Shoten will hold all of the company’s shares for the long term as a new major shareholder. As of the transfer dated June 11, 2026, Heise Shoten's voting rights ratio is 40.00%, and Tomoki Heise's...
Read more
Latest News (5 items)
Company Information
About
GENOVA, Inc. engages in the medical platform and smart clinic businesses in Japan. It offers Medical Doc, a platform that distributes articles for medical institutions, patient experience articles, treatment videos, and medical-related articles. It also provides Smart Clinic, an online medical treatment and consultation service, which offers medical treatment at home or work for users without going to a hospital. In addition, the company offers NOMOCa-Stand, a smart and simple automatic payment and reception machine; NOMOCa-Regi, a self-pay machine dedicated to the clinic; NOMOCaAIchat, an AI chat automatic response system; and CLINIC BOT, an AI Chatbot System. The company was incorporated in 2005 and is based in Tokyo, Japan.
